The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment.

Scientific Reports
Chia-Ying LinChen-Te Chou

Abstract

Drug-eluting bead transarterial chemoembolization (DEB-TACE) is the most common treatment for unresectable hepatocellular carcinoma (HCC). However, the effect of drug loading concentration and microsphere size on treatment outcomes remains unclear. This retrospective study compares the outcomes of 87 HCC patients who underwent DEB-TACE with half-loaded or full-loaded doxorubicin (maximum capacity 50 mg/mL) in 75-µm or 100-µm microspheres. Treatment with 100-μm microspheres resulted in significantly lower rates of procedure-related complications (6.6% vs. 26.9%; P < 0.05), post-embolization syndrome (32.8% vs. 61.5%, P < 0.05), SIR complications (32.8% vs. 61.5%; P < 0.01) and adverse events involving abdominal pain (19.7% vs. 42.3%; P < 0.05). Half-load doxorubicin microspheres resulted in greater treatment response (OR, 4.00; 95% CI 1.06-15.13; P, 0.041) and shorter hospital stays (OR, - 1.72; 95% CI - 2.77-0.68; P, 0.001) than did microspheres loaded to full capacity. Stratified analysis further showed that patients treated with 100-μm half-load doxorubicin microspheres had a higher CR (63.6% vs 18.0%) and ORR (90.9 vs 54.0%) and a shorter hospital stay (1.6 ± 1.3 vs 4.2 ± 2.3 days) than did those treated with full-load micro...Continue Reading

References

Apr 5, 2001·Journal of Vascular and Interventional Radiology : JVIR·D A LeungM C Soulen
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Sep 30, 2003·Journal of Vascular and Interventional Radiology : JVIR·David SacksCurtis A Lewis
Oct 28, 2004·Gastroenterology·Jordi BruixJosep M Llovet
Aug 23, 2006·Journal of Vascular and Interventional Radiology : JVIR·Andrew L LewisPeter W Stratford
May 8, 2007·Journal of Materials Science. Materials in Medicine·Andrew L LewisAndrew W Lloyd
Jul 9, 2009·Journal of Vascular and Interventional Radiology : JVIR·John F CardellaUNKNOWN Society of Interventional Radiology
Dec 25, 2010·Cardiovascular and Interventional Radiology·Katerina MalagariDimitrios Kelekis
Apr 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Philipp WiggermannChristian Stroszczynski
Aug 19, 2011·Journal of Vascular and Interventional Radiology : JVIR·Rodolfo SaccoCarlo Bartolozzi
Oct 20, 2011·Cardiovascular and Interventional Radiology·Riccardo LencioniJean-Francois H Geschwind
Dec 20, 2011·Journal of Vascular and Interventional Radiology : JVIR·Matthew R DreherBradford J Wood
Jan 31, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andrew L Lewis, Matthew R Dreher
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Feb 6, 2013·Journal of Vascular and Interventional Radiology : JVIR·Siddharth A PadiaMatthew J Kogut
Jun 12, 2013·Cardiovascular and Interventional Radiology·Sanjeeva P KalvaAndrew X Zhu
May 28, 2014·Journal of Vascular and Interventional Radiology : JVIR·Toshihiro TanakaKimihiko Kichikawa
Feb 24, 2015·Journal of Vascular and Interventional Radiology : JVIR·Daniel M GnutzmannUlrike Stampfl
Feb 24, 2015·Journal of Vascular and Interventional Radiology : JVIR·Amy R DeipolyiSuvranu Ganguli
May 17, 2015·Journal of Vascular and Interventional Radiology : JVIR·Bruno C OdisioAlda L Tam
Sep 4, 2015·Journal of Gastroenterology and Hepatology·Antonio FacciorussoVincenzo Mazzaferro
Jan 4, 2017·Gastroenterology·Daniela SiaJosep M Llovet
Feb 12, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Koorosh AshrafiAndrew L Lewis
Jun 22, 2017·World Journal of Radiology·Giorgio GrecoCarlo Spreafico
Jul 15, 2017·World Journal of Hepatology·Jeong Eun Song, Do Young Kim
Jan 30, 2018·World Journal of Gastroenterology : WJG·Antonio Facciorusso
Jun 29, 2018·Future Oncology·Julien DelicqueChristophe Cassinotto
Apr 16, 2019·Gastroenterology·Fasiha Kanwal, Amit G Singal
May 7, 2019·Gut and Liver·UNKNOWN Korean Liver Cancer Association, UNKNOWN National Cancer Center
Aug 24, 2019·Nature Reviews. Gastroenterology & Hepatology·Ju Dong YangLewis R Roberts
Jun 20, 2020·Cellular and Molecular Neurobiology·Zatollah AsemiOmid Reza Tamtaji

❮ Previous
Next ❯

Software Mentioned

TANDEM
SAS

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.